Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
about
Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusionEconomic considerations of macular edema therapiesGrid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion.Diabetic retinopathy - An update.The ABCs of RVO: a review of retinal venous occlusion.Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trialEffect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.Anti-angiogenic therapy (bevacizumab) in the management of oral lichen planus.SCORE2 Report 2: Study Design and Baseline Characteristics.Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results.
P2860
Q24234625-A46A9141-C69F-4138-9A9D-267C9A66D42EQ33878122-72B61D5E-B929-4B25-AAE1-38DF86BA2B8AQ33993712-61C97723-45B8-4CBB-8A70-A8AF6184BE8AQ34957902-C67643C5-0D46-4AFD-ABDE-D8347304EF48Q35047634-C98DA459-D154-4DA9-83C6-245DD3920311Q36764757-BABEA25F-6E46-49E3-88B4-7B3EB48541E7Q38792697-79955972-4C86-4336-BADD-91C727C03533Q39986140-61B5E2BD-A7BE-40FA-9CCF-CF7F75321C3DQ46169738-9E5C5130-CDF9-4DB0-8455-A083938D2778Q52889544-92F2E9D7-FA91-4F4E-8449-4E8DE217BB52
P2860
Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Comparison of two doses of int ...... tina study group at 24 months.
@en
Comparison of two doses of int ...... tina study group at 24 months.
@nl
type
label
Comparison of two doses of int ...... tina study group at 24 months.
@en
Comparison of two doses of int ...... tina study group at 24 months.
@nl
prefLabel
Comparison of two doses of int ...... tina study group at 24 months.
@en
Comparison of two doses of int ...... tina study group at 24 months.
@nl
P2093
P1433
P1476
Comparison of two doses of int ...... tina study group at 24 months.
@en
P2093
Arturo A Alezzandrini
J Fernando Arevalo
José A Roca
Manuel J Díaz-Llopis
Maria H Berrocal
Virgilio Morales-Cantón
P304
P356
10.1097/IAE.0B013E3181CEA68D
P577
2010-07-01T00:00:00Z